Literature DB >> 29596798

Neuroprotective effect of paeoniflorin on okadaic acid-induced tau hyperphosphorylation via calpain/Akt/GSK-3β pathway in SH-SY5Y cells.

Xiao-Hui Ma1, Wen-Jun Duan2, You-Sheng Mo1, Jun-Li Chen1, Shi Li1, Wei Zhao1, Lei Yang1, Sui-Qing Mi1, Xin-Liang Mao3, Hong Wang4, Qi Wang5.   

Abstract

Abnormal phosphorylation of tau, one of the most common symptoms of dementia, has become increasingly important in the study of the etiology and development of Alzheimer's disease. Paeoniflorin, the main bioactive component of herbaceous peony, is a monoterpene glycoside, which has been reported to exert beneficial effects on neurodegenerative disease. However, the effect of paeoniflorin on tauopathies remains ambiguous. SH-SY5Y cells were treated with okadaic acid (OA) for 8 h to induce tau phosphorylation and no cell death was observed. Optical microscopy results showed that paeoniflorin ameliorated okadaic acid induced morphological changes, including cell swelling and synapsis shortening. Western blotting data illustrated that paeoniflorin reversed okadaic acid induced tau hyperphosphorylation, which was enhanced by inhibiting the activities of calpain, Akt and GSK-3β. Transmission electron microscopy results showed that paeoniflorin alone can reduce the number of autophagosomes and stabilize the microtubule structure. In addition, calpastain and paeoniflorin enhance the effect of paeoniflorin on stabilizing microtubules. In addition, calpastain markedly enhanced the effect of paeoniflorin on reversing okadaic acid-lowered fluorescence intensity of both MAP-2 and β III-tubulin, two microtubule-associated proteins. This study shows that paeoniflorin protected SH-SY5Y cells against okadaic acid assault by interfering with the calpain/Akt/GSK-3β-related pathways, in which autophagy might be involved. Besides, paeoniflorin is found to relieve the stress response of the microtubule structure system caused by okadaic acid treatment. The results presented in this study suggest that paeoniflorin potentially plays an important role in tauopathies.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Autophagy; Paeoniflorin; Tau; μ-calpain

Mesh:

Substances:

Year:  2018        PMID: 29596798     DOI: 10.1016/j.brainres.2018.03.022

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Cryptotanshinone Attenuates Amyloid-β42-induced Tau Phosphorylation by Regulating PI3K/Akt/GSK3β Pathway in HT22 Cells.

Authors:  Diyang Lyu; Jianping Jia
Journal:  Mol Neurobiol       Date:  2022-05-16       Impact factor: 5.590

2.  Paeoniflorin Ameliorates BiPN by Reducing IL6 Levels and Regulating PARKIN-Mediated Mitochondrial Autophagy.

Authors:  Runjie Sun; Jiang Liu; Manya Yu; Mengting Xia; Yanyu Zhang; Xiaoqi Sun; Yunsheng Xu; Xing Cui
Journal:  Drug Des Devel Ther       Date:  2022-07-13       Impact factor: 4.319

3.  Robust Dopaminergic Differentiation and Enhanced LPS-Induced Neuroinflammatory Response in Serum-Deprived Human SH-SY5Y Cells: Implication for Parkinson's Disease.

Authors:  Aram Niaz; Jocelyn Karunia; Mawj Mandwie; Kevin A Keay; Giuseppe Musumeci; Ghaith Al-Badri; Alessandro Castorina
Journal:  J Mol Neurosci       Date:  2020-08-13       Impact factor: 3.444

4.  Paeoniflorin ameliorates ischemic injury in rat brain via inhibiting cytochrome c/caspase3/HDAC4 pathway.

Authors:  Yi-Fei Liu; Lei Zhang; Qi Wu; Lin-Yin Feng
Journal:  Acta Pharmacol Sin       Date:  2021-05-11       Impact factor: 6.150

Review 5.  Recent Insights Into the Protective Mechanisms of Paeoniflorin in Neurological, Cardiovascular, and Renal Diseases.

Authors:  Feng Jiao; Kevin Varghese; Shaoxun Wang; Yedan Liu; Hongwei Yu; George W Booz; Richard J Roman; Ruen Liu; Fan Fan
Journal:  J Cardiovasc Pharmacol       Date:  2021-06-01       Impact factor: 3.271

6.  Self-Assembling Peptide Scaffold Carrying Neural-Cell Adhesion Molecule-Derived Mimetic-Peptide Transplantation Promotes Proliferation and Stimulates Neurite Extension by Modulating Tau Phosphorylation and Calpain/Glycogen Synthase Kinase 3 beta (GSK-3β) in Neurons.

Authors:  Jian Xu; Jing Feng; Yu-Dong Liu; Tao Hu; Ming-Jing Li; Fan Li
Journal:  Ann Transplant       Date:  2020-07-07       Impact factor: 1.530

Review 7.  Multiple Roles of Paeoniflorin in Alzheimer's Disease.

Authors:  Zeyu Meng; Huize Chen; Chujun Deng; Shengxi Meng
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-11       Impact factor: 2.650

8.  "Drug-Carrier" Synergy Therapy for Amyloid-β Clearance and Inhibition of Tau Phosphorylation via Biomimetic Lipid Nanocomposite Assembly.

Authors:  Guochen Han; Kaiwen Bai; Xiaoyu Yang; Chenhua Sun; Yi Ji; Jianping Zhou; Huaqing Zhang; Yang Ding
Journal:  Adv Sci (Weinh)       Date:  2022-03-20       Impact factor: 17.521

9.  Yuan-Zhi decoction in the treatment of Alzheimer's disease: An integrated approach based on chemical profiling, network pharmacology, molecular docking and experimental evaluation.

Authors:  Qiong Wu; Xiang Li; Xiao-Wen Jiang; Dong Yao; Li-Jun Zhou; Zi-Hua Xu; Nan Wang; Qing-Chun Zhao; Zhou Zhang
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

10.  A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Paeonia lactiflora Pall. On the Treatment of Alzheimer's Disease.

Authors:  Qiang Zeng; Longfei Li; Yu Jin; Zongzheng Chen; Lihong Duan; Meiqun Cao; Min Ma; Zhengzhi Wu
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.